- Home
- OKE vs SNN Comparison
OKE vs SNN Comparison
Compare OKE & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OKE
- SNN
- Stock Information
- Founded
- OKE 1906
- SNN 1856
- Country
- OKE United States
- SNN United Kingdom
- Employees
- OKE N/A
- SNN N/A
- Industry
- OKE Oil & Gas Production
- SNN Industrial Specialties
- Sector
- OKE Utilities
- SNN Health Care
- Exchange
- OKE Nasdaq
- SNN Nasdaq
- Market Cap
- OKE 54.9B
- SNN 12.6B
- IPO Year
- OKE N/A
- SNN 1999
- Fundamental
- Price
- OKE $81.82
- SNN $30.28
- Analyst Decision
- OKE Buy
- SNN Hold
- Analyst Count
- OKE 14
- SNN 3
- Target Price
- OKE $103.43
- SNN $27.50
- AVG Volume (30 Days)
- OKE 4.0M
- SNN 915.5K
- Earning Date
- OKE 08-04-2025
- SNN 07-31-2025
- Dividend Yield
- OKE 5.02%
- SNN 2.38%
- EPS Growth
- OKE 18.10
- SNN 56.15
- EPS
- OKE 5.11
- SNN 0.47
- Revenue
- OKE $24,960,000,000.00
- SNN $5,810,000,000.00
- Revenue This Year
- OKE $29.67
- SNN $6.87
- Revenue Next Year
- OKE $2.22
- SNN $5.19
- P/E Ratio
- OKE $16.08
- SNN $32.11
- Revenue Growth
- OKE 39.15
- SNN 4.70
- 52 Week Low
- OKE $75.48
- SNN $23.69
- 52 Week High
- OKE $118.07
- SNN $31.72
- Technical
- Relative Strength Index (RSI)
- OKE 50.91
- SNN 60.00
- Support Level
- OKE $80.05
- SNN $29.99
- Resistance Level
- OKE $82.02
- SNN $30.77
- Average True Range (ATR)
- OKE 1.77
- SNN 0.40
- MACD
- OKE 0.19
- SNN 0.04
- Stochastic Oscillator
- OKE 50.33
- SNN 79.32
About OKE ONEOK Inc.
Oneok is a diversified midstream service provider specializing in natural gas gathering, processing, storage, and transportation and natural gas liquids transportation and fractionation. It also operates a refined product and crude oil segment connecting producers, refiners, and consumers. Operations are in the midcontinent, Permian, and Rocky Mountain regions.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.